HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[GNAS1 gene abnormality in pseudohypoparathyroidism I a].

Abstract
Pseudophypoparathyroidism (PHP) is characterized by hypocalcemia, hyperphosphatemia and elevated levels of parathyroid hormone (PTH) due to resistance to PTH. PHP type I a is caused by heterozygous inactivating mutation of the GNAS1 gene, which encodes signal transducer, Gsalpha. PHP type I a is associated with Albright's osteodystrophy (AHO). Those patients who have AHO phenotype without hormone resistance are affected by pseudopseudohypoparathyroidism.
AuthorsKeiichi Ozono
JournalClinical calcium (Clin Calcium) Vol. 17 Issue 8 Pg. 1214-9 (Aug 2007) ISSN: 0917-5857 [Print] Japan
PMID17660618 (Publication Type: Journal Article, Review)
Chemical References
  • Chromogranins
  • Hydroxycholecalciferols
  • GNAS protein, human
  • GTP-Binding Protein alpha Subunits, Gs
  • Calcitriol
  • alfacalcidol
Topics
  • Calcitriol (therapeutic use)
  • Chromogranins
  • Fibrous Dysplasia, Polyostotic (genetics)
  • GTP-Binding Protein alpha Subunits, Gs (genetics)
  • Humans
  • Hydroxycholecalciferols (therapeutic use)
  • Mutation
  • Pseudohypoparathyroidism (diagnosis, drug therapy, genetics)
  • Pseudopseudohypoparathyroidism (genetics)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: